International Conference on Brain Disorders and Therapeutics August 24-26, 2015 London, UK
Exploring the Challenges and Recent Innovations in Prevention, Diagnosis and Treatment of Brain Disorders
Brain Disorders-2015 welcomes attendees, presenters, and exhibitors from all over the world to London, UK. We are delighted to invite you all to attend and register for the “International Conference on Brain Disorders and Therapeutics”, which is going to be held during August 24-26, 2015 in London, UK. International Conference on Brain Disorders and Therapeutics is a unique forum to bring together worldwide distinguished academics in the field of neuroscience and neurology, Brain researchers, public health professionals, scientists, academic scientists, industry researchers, scholars to exchange about state of the art research and technologies.
Aim of this conference is stimulate new ideas for treatment that will be beneficial across the spectrum of Brain disorders. Our goal is to deliver an outstanding program which covers the entire spectrum of research in brain and share the cross-cultural experiences of various treatment procedures of Brain Disorders. Researchers around the world are unlocking mysteries of the brain and causes of brain diseases in a “quiet neuroscience revolution” that, some say, will transform the way mental illness has been diagnosed and treated for the past 50 years. This International Conference throws light on the following topics like, Brain Disorder Manifestation, Pathophysiology, Brain Disorder: Anticipatory Measure and Pervasiveness, Diagnosis: Analysis, Assessment and Psychoanalysis, Associated Disorders, Neurodegeneration in Stroke: Brain Attack, and many more.
For more details please visit- http://braindisorders.conferenceseries.com/
Importance and Scope:
Brain Disorders are the most common cause of serious disability and have a major but often unrecognized, impact on health and social services. There are 10 million people in the UK living with a neurological condition which has a significant impact on their lives. Mainly stroke, epilepsy, dementia, chiari malformation, headache, head injury and cerebrovascular disease are the neurological conditions suffered in UK. It has been estimated that the lifetime risk of developing brain and other central nervous system cancer is 1 in 133 for men and 1 in 185 for women in the UK. Each year 600,000 people (1% of the UK population) are newly diagnosed with a brain disorders condition. Primary brain tumor represents about 1.6% of all tumors diagnosed in the UK. The aggregate costs of all mental disorders in the United Kingdom are £32 billion.
Glance at Market of Brain Disorders and Therapeutics Industry:
National Alliance provided fund of $650 million to fuel the research on mental illness. NARSAD Young Investigator Grant provides $30,000 per year on research in brain and behavior disorders such as schizophrenia, mood disorders, anxiety disorders, or child and adolescent mental illnesses. Brain tumor research receives less than 1% (0.7%) of national cancer research spending in the UK. Scientific breakthroughs over the past decade have created enough optimism among the world’s experts that some dare to talk about a “cure” for depression and other mental illness, the non-infectious disease that is rapidly becoming one of the biggest global public health challenges. The change in knowledge will lead to a whole new approach to treatment. It will change the way we treat these conditions because we will now have the opportunity to treat them based on causes, not just based on appearance or symptoms.
About 5,000 Americans suffer a traumatic brain injury every year, according to the Centers for Disease Control and Prevention. A total of 13,000 North Dakotans are dealing with the consequences of TBI, some of which, research shows, include the risk of developing mental disorders such as depression, schizophrenia and bipolar disorder.
Management and treatment of schizophrenia has always been difficult with the cause being exactly untraceable. Although it is known that the risk of suffering from schizophrenia is hereditary, the specific genes that cause the disease had not yet been identified. Researchers have now found that schizophrenia consists of eight different types of brain disorders each of which has its own signs and symptoms, and is not one single disease. It is an important first step towards better diagnosis and treatment of schizophrenia.
World-renowned speakers, with their eminent talks on the most recent techniques, tactics, and latest breakthroughs in the field of Brain Disorders and Therapeutics define the hallmarks of this conference.
A Unique Opportunity for Advertisers and Sponsors at this International event: